RO85815B - Procedeu pentru prepararea unor derivati de tiazol - Google Patents

Procedeu pentru prepararea unor derivati de tiazol

Info

Publication number
RO85815B
RO85815B RO110860A RO11086081A RO85815B RO 85815 B RO85815 B RO 85815B RO 110860 A RO110860 A RO 110860A RO 11086081 A RO11086081 A RO 11086081A RO 85815 B RO85815 B RO 85815B
Authority
RO
Romania
Prior art keywords
alkyl
thiazole derivatives
hydrogen
carbon atoms
general formula
Prior art date
Application number
RO110860A
Other languages
English (en)
Romanian (ro)
Other versions
RO85815A (ro
Inventor
Richard Paul Pioch
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22712591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RO85815(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of RO85815A publication Critical patent/RO85815A/ro
Publication of RO85815B publication Critical patent/RO85815B/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RO110860A 1980-10-02 1981-10-01 Procedeu pentru prepararea unor derivati de tiazol RO85815B (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/193,192 US4375547A (en) 1980-10-02 1980-10-02 N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Publications (2)

Publication Number Publication Date
RO85815A RO85815A (ro) 1984-11-25
RO85815B true RO85815B (ro) 1984-11-30

Family

ID=22712591

Family Applications (2)

Application Number Title Priority Date Filing Date
RO110860A RO85815B (ro) 1980-10-02 1981-10-01 Procedeu pentru prepararea unor derivati de tiazol
RO81105440A RO82215A (ro) 1980-10-02 1981-10-01 Procedeu pentru prepareaea unor derivati de tiazol

Family Applications After (1)

Application Number Title Priority Date Filing Date
RO81105440A RO82215A (ro) 1980-10-02 1981-10-01 Procedeu pentru prepareaea unor derivati de tiazol

Country Status (36)

Country Link
US (1) US4375547A (enExample)
EP (1) EP0049618B1 (enExample)
JP (1) JPS5791980A (enExample)
KR (1) KR850001795B1 (enExample)
AR (1) AR241439A1 (enExample)
AU (1) AU542553B2 (enExample)
BG (1) BG60249B2 (enExample)
CA (1) CA1166248A (enExample)
CS (1) CS227015B2 (enExample)
CY (1) CY1351A (enExample)
DD (1) DD200371A5 (enExample)
DE (1) DE3171819D1 (enExample)
DK (2) DK164056C (enExample)
EG (1) EG15678A (enExample)
ES (2) ES8301950A1 (enExample)
FI (2) FI76570C (enExample)
GB (1) GB2084581B (enExample)
GR (1) GR75023B (enExample)
HK (1) HK15987A (enExample)
HU (1) HU188697B (enExample)
IE (1) IE51603B1 (enExample)
IL (1) IL63980A (enExample)
LU (1) LU88293I2 (enExample)
MX (1) MX5723A (enExample)
MY (1) MY8700247A (enExample)
NL (1) NL930107I2 (enExample)
NO (1) NO155885C (enExample)
NZ (1) NZ198523A (enExample)
PH (1) PH18135A (enExample)
PL (2) PL130526B1 (enExample)
PT (1) PT73757B (enExample)
RO (2) RO85815B (enExample)
SU (1) SU1184443A3 (enExample)
UA (1) UA6081A1 (enExample)
YU (1) YU42728B (enExample)
ZA (1) ZA816817B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
US4474794A (en) * 1982-03-19 1984-10-02 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
FR2531703A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa 2-aza-5-thiahexan-1-ones 1,6-disubstituees, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
ES8601941A1 (es) * 1983-02-07 1985-11-01 Lilly Co Eli Un procedimiento para la preparacion de nizatidina
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
US4468517A (en) * 1983-05-12 1984-08-28 Eli Lilly And Company Synthesis of thiazoles
DE3417127A1 (de) * 1984-05-09 1985-11-14 Papst-Motoren GmbH & Co KG, 7742 St Georgen Kleinstventilator
DE3531504A1 (de) * 1985-09-04 1987-03-12 Basf Ag 3-aminomethylpyrrol-1-yl-alkylamine und diese verbindungen enthaltende therapeutische mittel
IL80961A0 (en) * 1985-12-18 1987-03-31 Lilly Co Eli Synthesis of nizatidine
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
EP0285681B1 (de) 1987-04-06 1993-03-10 HEUMANN PHARMA GMBH & CO Verfahren zur Herstellung von Nitroethenderivaten
ES2007959A6 (es) * 1988-07-11 1989-07-01 Vinas Lab Procedimiento para la obtencion de derivados tiazolicos.
EP0960880A1 (en) * 1991-05-21 1999-12-01 Eli Lilly And Company Process for preparing intermediates to nizatidine and related compounds
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
CA2134229A1 (en) * 1992-05-12 1993-11-13 Osamu Kitagawa Novel quaternary ammonium salts and use thereof as medicine
US5541335A (en) * 1994-07-11 1996-07-30 Torcan Chemical Ltd. Process for preparing nizatidine
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition
WO1998011081A1 (en) * 1996-09-11 1998-03-19 Knoll Aktiengesellschaft Process for the preparation of nizatidine
IT1299198B1 (it) 1998-03-05 2000-02-29 Nicox Sa Sali nitrati di farmaci antiulcera
US6552047B2 (en) 1998-11-17 2003-04-22 Nitromed, Inc. H2 receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US20080044481A1 (en) * 2004-05-27 2008-02-21 Mordechai Harel Microparticles for Oral Delivery
WO2006071659A1 (en) * 2004-12-29 2006-07-06 Trustees Of Boston University Delivery of h2 antagonists
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US20090275622A1 (en) * 2008-04-30 2009-11-05 Prasoona Linga Nizatidine formulations
US10398705B2 (en) 2012-03-15 2019-09-03 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
AU2014292086B2 (en) 2013-07-19 2019-08-08 Boehringer Ingelheim Vetmedica Gmbh Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
MX375936B (es) 2013-12-04 2025-03-07 Boehringer Ingelheim Vetmedica Gmbh Composiciones farmaceuticas mejoradas de pimobendan.
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
EP2942058A1 (en) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3917593A (en) * 1972-05-22 1975-11-04 Smithkline Corp N-alkenyl and N-alkynyl (2-quinolyl)thio-acetamides
US3853865A (en) * 1972-06-26 1974-12-10 Smithkline Corp N-aminomethyl-2-amino(and 2-amino-methyl)-2-heterocyclic-thioacetamides
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4191769A (en) * 1974-03-12 1980-03-04 Smith Kline & French Laboratories Limited Isothiourea compounds and pharmacological use
US4061637A (en) * 1974-05-14 1977-12-06 Istituto Luso Farmaco D'italia S.R.L. Certain 4-aryl-5-(4-phenylpiperazino)alkyl-4-thiazolin-2-ones
US4173644A (en) * 1975-02-03 1979-11-06 Smith Kline & French Laboratories Limited Thiourea compounds, compositions and methods and use
US4166856A (en) * 1975-05-21 1979-09-04 Smith Kline & French Laboratories Limited Thiazole and isothiazole derivative as blockers of histamine H2 -receptors
GB1574214A (en) * 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
GB1602458A (en) * 1977-05-05 1981-11-11 Smith Kline French Lab Bisamidines as histamine h2-antagonists
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
US4210658A (en) * 1977-09-08 1980-07-01 Smith Kline & French Laboratories Limited Amidinosulphonic acid derivatives
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
EP0006679B1 (en) * 1978-05-24 1982-07-21 Imperial Chemical Industries Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives

Also Published As

Publication number Publication date
DK164056B (da) 1992-05-04
PL238035A1 (en) 1983-02-28
DK435181A (da) 1982-05-12
ES514868A0 (es) 1983-05-01
DK12391A (da) 1991-01-24
PT73757A (en) 1981-11-01
JPH021141B2 (enExample) 1990-01-10
FI813058L (fi) 1982-04-03
KR850001795B1 (ko) 1985-12-21
NL930107I1 (nl) 1993-10-18
ES505950A0 (es) 1983-01-01
RO85815A (ro) 1984-11-25
EP0049618A1 (en) 1982-04-14
IE51603B1 (en) 1987-01-21
DK167759B1 (da) 1993-12-13
DK12391D0 (da) 1991-01-24
HK15987A (en) 1987-02-27
JPS5791980A (en) 1982-06-08
HU188697B (en) 1986-05-28
FI76570B (fi) 1988-07-29
FI76570C (fi) 1988-11-10
GB2084581B (en) 1985-02-27
GR75023B (enExample) 1984-07-12
KR830007602A (ko) 1983-11-04
NO813334L (no) 1982-04-05
YU236481A (en) 1983-10-31
LU88293I2 (fr) 1994-05-04
UA6081A1 (uk) 1994-12-29
MX5723A (es) 1993-12-01
PL233295A1 (enExample) 1982-12-20
YU42728B (en) 1988-12-31
AU542553B2 (en) 1985-02-28
AU7594581A (en) 1982-04-08
CA1166248A (en) 1984-04-24
ZA816817B (en) 1983-05-25
DK164056C (da) 1992-09-28
PT73757B (en) 1983-01-13
RO82215A (ro) 1983-07-07
PL130626B1 (en) 1984-08-31
DD200371A5 (de) 1983-04-20
EP0049618B1 (en) 1985-08-14
SU1184443A3 (ru) 1985-10-07
NO155885B (no) 1987-03-09
PL130526B1 (en) 1984-08-31
GB2084581A (en) 1982-04-15
IL63980A (en) 1986-04-29
RO82215B (ro) 1983-06-30
US4375547A (en) 1983-03-01
IL63980A0 (en) 1982-01-31
ES8306135A1 (es) 1983-05-01
BG60249B1 (bg) 1994-03-24
ES8301950A1 (es) 1983-01-01
MY8700247A (en) 1987-12-31
AR241439A1 (es) 1992-07-31
EG15678A (en) 1986-12-30
BG60249B2 (en) 1994-03-24
PH18135A (en) 1985-04-03
NZ198523A (en) 1985-12-13
CS227015B2 (en) 1984-04-16
CY1351A (en) 1987-04-24
NO155885C (no) 1987-06-17
NL930107I2 (nl) 1997-02-03
IE812285L (en) 1982-04-02
DE3171819D1 (en) 1985-09-19

Similar Documents

Publication Publication Date Title
RO82215B (ro) Procedeu pentru prepararea unor derivati de tiazol
YU48997B (sh) Fluoroalkoksibenzilamino derivati heterociličnih jedinjenja koja sadrže azot
FI865037A7 (fi) Mikrobicida kompositioner.
RO83311B (ro) Procedeu de preparare a unor saruri de monoester de acid fosforic
IL51133A (en) 1-alkyl-6,8 alpha-disubstituted ergoline derivatives,their production and pharmaceutical compositions containing them
JO1255B1 (en) Various compounds loops
RO84096B (ro) Procedeu de preparare a unor derivati heterociclici
ES476863A1 (es) Un procedimiento para la preparacion de nuevos derivados de anilina.
ES8603837A1 (es) Un procedimiento para la preparacion de derivados de pirazol
KR850000755B1 (en) Process for preparing 3,1-benzoxazin-2-ones and acid addition salts thereof
ES439548A1 (es) Procedimiento para preparar derivados de ergolina.
ES474155A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalquilfurano
MY109714A (en) Process for preparing 8-chloroquinolone derivatives
FR2504528B1 (enExample)
PL245747A1 (en) Process for preparing novel,base-substituted 4-phenyl-4,5,6,7-tetrahydro-thieno/2,3-c/pyridines
RO85385B (ro) Procedeu pentru prepararea unor derivati de tiazol
GB1098736A (en) New anthraquinone dyestuffs and processes for their manufacture and use
DK48188D0 (da) Ergolinyl-heterocycliske forbindelser og fremgangsmaade til fremstilling deraf
FR2494275B2 (enExample)
RO83468B (ro) Procedeu de obtinere a derivatilor de 5, 6, 7, 7a-tetrahidro-4h-tieno(3, 2-c)-piridin-2-onei
GB1005028A (en) Novel 1:4-benzodioxan derivatives
ES276073A1 (es) Procedimiento de preparación de nuevos derivados de la oxazolidinona
ES451293A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina.
GB2006771A (en) Substituted Heterocyclic Compounds, their Preparation and Pharmaceutical Compositions Containing them
ES423745A1 (es) Procedimiento para preparar derivados de 2-aminoindano.